{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:13:22Z","timestamp":1789737202309,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28108-3","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:04:37Z","timestamp":1780974277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying communities at elevated risk of hepatitis C infection in Los Angeles County: an ecological study using machine learning"],"prefix":"10.1186","volume":"26","author":[{"given":"Jacob Mugoya","family":"Gizamba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Ruddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"3","key":"28108_CR1","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","volume":"69","author":"MG Hofmeister","year":"2019","unstructured":"Hofmeister MG, Rosenthal EM, Barker LK, Rosenberg ES, Barranco MA, Hall EW, et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016. Hepatology. 2019;69(3):1020\u201331.","journal-title":"Hepatology"},{"issue":"2","key":"28108_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","volume":"69","author":"S Schillie","year":"2020","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020. MMWR Recomm Rep. 2020;69(2):1\u201317.","journal-title":"MMWR Recomm Rep"},{"issue":"14","key":"28108_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.15585\/mmwr.mm6914a2","volume":"69","author":"AB Ryerson","year":"2020","unstructured":"Ryerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital signs: newly reported acute and chronic hepatitis C cases\u2015United States, 2009\u20132018. Morb Mortal Wkly Rep. 2020;69(14):399.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2","key":"28108_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175\u201381.","journal-title":"Am J Public Health"},{"key":"28108_CR5","doi-asserted-by":"publisher","unstructured":"Bhattacharya D, Aronsohn A, Price J, Lo Re V. The American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America HCV Guidance Panel , Hepatitis C Guidance 2023 Update: american association for the study of liver diseases\u2013 infectious diseases society of america recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. 2023;ciad319. https:\/\/doi.org\/10.1093\/cid\/ciad319.","DOI":"10.1093\/cid\/ciad319"},{"issue":"2","key":"28108_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","volume":"15","author":"DC Perlman","year":"2018","unstructured":"Perlman DC, Jordan AE. The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. Curr HIV\/AIDS Rep. 2018;15(2):96\u2013112.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10072","key":"28108_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0140-6736(17)30003-X","volume":"389","author":"M Singer","year":"2017","unstructured":"Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941\u201350.","journal-title":"Lancet"},{"issue":"3","key":"28108_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"},{"key":"28108_CR9","doi-asserted-by":"publisher","unstructured":"Kolak MA, Chen YT, Joyce S, Ellis K, Defever K, McLuckie C et al. Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective. Int J Drug Policy. 2020;85:102727. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102727.","DOI":"10.1016\/j.drugpo.2020.102727"},{"key":"28108_CR10","doi-asserted-by":"publisher","unstructured":"Clarisse A, Tsang J, Tonzel H, Symum HW, Kaufman WA, Meyer III, Osinubi A et al. State-Specific Hepatitis C Virus Clearance Cascades \u2014 United States, 2013\u201322. 2024. https:\/\/doi.org\/10.15585\/mmwr.mm7321a4.","DOI":"10.15585\/mmwr.mm7321a4"},{"issue":"10","key":"28108_CR11","doi-asserted-by":"publisher","first-page":"e0293315","DOI":"10.1371\/journal.pone.0293315","volume":"18","author":"K Gnanapandithan","year":"2023","unstructured":"Gnanapandithan K, Ghali MP. Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey. PLoS ONE. 2023;18(10):e0293315.","journal-title":"PLoS ONE"},{"key":"28108_CR12","unstructured":"The White House. National HIV\/AIDS Strategy for the United States 2022\u20132025. Office of National AIDS Policy. 2021. https:\/\/files.hiv.gov\/s3fs-public\/NHAS-2022-2025.pdf."},{"key":"28108_CR13","unstructured":"US Department of Health and Human Services. Viral hepatitis national strategic plan for the United States: a roadmap to elimination (2021\u20132025). Washington, DC, USA: US Department of Health and Human Services; 2020 https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf."},{"key":"28108_CR14","unstructured":"California Department of Public Health. California Fatal Opioid Overdose and HIV or Hepatitis C Virus (HCV) Vulnerability Assessment. California Department of Public Health; 2018. https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/VA_PublicReport.pdf."},{"issue":"4","key":"28108_CR15","doi-asserted-by":"publisher","first-page":"ofad125","DOI":"10.1093\/ofid\/ofad125","volume":"10","author":"C Hernandez-Tamayo","year":"2023","unstructured":"Hernandez-Tamayo C, Stafylis C, Klausner JD. Lack of Hepatitis C Virus Elimination by 2030 in Los Angeles County at Current Treatment Rate. Open Forum Infect Dis. 2023;10(4):ofad125.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"28108_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11414-018-9586-y","volume":"45","author":"A Acevedo","year":"2018","unstructured":"Acevedo A, Panas L, Garnick D, Acevedo-Garcia D, Miles J, Ritter G, et al. Disparities in the treatment of substance use disorders: does where you live matter? J Behav Health Serv Res. 2018;45(4):533\u201349.","journal-title":"J Behav Health Serv Res"},{"issue":"3","key":"28108_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"28108_CR18","doi-asserted-by":"publisher","first-page":"107490","DOI":"10.1016\/j.ypmed.2023.107490","volume":"170","author":"S Shrestha","year":"2023","unstructured":"Shrestha S, Bayly R, Pustz J, Sawyer J, Van Handel M, Lingwall C, et al. Methods for jurisdictional vulnerability assessment of opioid-related outcomes. Prev Med. 2023;170:107490.","journal-title":"Prev Med"},{"key":"28108_CR19","doi-asserted-by":"publisher","first-page":"106040","DOI":"10.1016\/j.ypmed.2020.106040","volume":"134","author":"N Sharareh","year":"2020","unstructured":"Sharareh N, Hess R, White S, Dunn A, Singer PM, Cochran J. A vulnerability assessment for the HCV infections associated with injection drug use. Prev Med. 2020;134:106040.","journal-title":"Prev Med"},{"issue":"11","key":"28108_CR20","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/cid\/cix1079","volume":"66","author":"M Rickles","year":"2018","unstructured":"Rickles M, Rebeiro PF, Sizemore L, Juarez P, Mutter M, Wester C, et al. Tennessee\u2019s In-state Vulnerability Assessment for a Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection Event Utilizing Data About the Opioid Epidemic. Clin Infect Dis. 2018;66(11):1722\u201332.","journal-title":"Clin Infect Dis"},{"key":"28108_CR21","doi-asserted-by":"publisher","first-page":"652672","DOI":"10.3389\/fsoc.2021.652672","volume":"6","author":"CJ Bergo","year":"2021","unstructured":"Bergo CJ, Epstein JR, Hoferka S, Kolak MA, Pho MT. A vulnerability assessment for a future HIV outbreak associated with injection drug use in Illinois, 2017\u20132018. Front Sociol. 2021;6:652672.","journal-title":"Front Sociol"},{"issue":"12","key":"28108_CR22","first-page":"2222","volume":"188","author":"Q Bi","year":"2019","unstructured":"Bi Q, Goodman KE, Kaminsky J, Lessler J. What is machine learning? A primer for the epidemiologist. Am J Epidemiol. 2019;188(12):2222\u201339.","journal-title":"Am J Epidemiol"},{"key":"28108_CR23","doi-asserted-by":"publisher","unstructured":"Yedinak JL, Li Y, Krieger MS, Howe K, Ndoye CD, Lee H et al. Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak. Int J Drug Policy. 2021;96:103395. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103395.","DOI":"10.1016\/j.drugpo.2021.103395"},{"issue":"1","key":"28108_CR24","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1080\/07853890.2022.2105391","volume":"54","author":"TS Bartholomew","year":"2022","unstructured":"Bartholomew TS, Tookes HE, Spencer EC, Feaster DJ. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017. Ann Med. 2022;54(1):2137\u201350.","journal-title":"Ann Med"},{"key":"28108_CR25","doi-asserted-by":"crossref","unstructured":"Buckley GJ, Strom BL. Eliminating the public health problem of hepatitis B and C in the United States: Phase one report. National Academies; 2016. p. 1\u2013186.","DOI":"10.17226\/23407"},{"issue":"6","key":"28108_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","volume":"4","author":"A Trickey","year":"2019","unstructured":"Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol Hepatol. 2019;4(6):435\u201344.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"28108_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12889-025-21668-w","volume":"25","author":"JM Gizamba","year":"2025","unstructured":"Gizamba JM, Finch BK, Wang S, Klausner JD. Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses. BMC Public Health. 2025;25(1):687.","journal-title":"BMC Public Health"},{"key":"28108_CR28","unstructured":"California Overdose Surveillance Dashboard. Prepared by California Department of Public Health (CDPH) - Substance and Addiction Prevention Branch (SAPB). Available from: https:\/\/skylab.cdph.ca.gov\/ODdash\/.\u00a0\u00a0cited 01\/16\/25."},{"issue":"10","key":"28108_CR29","doi-asserted-by":"publisher","first-page":"e23173","DOI":"10.2196\/23173","volume":"22","author":"PS Sullivan","year":"2020","unstructured":"Sullivan PS, Woodyatt C, Koski C, Pembleton E, McGuinness P, Taussig J, et al. A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource. J Med Internet Res. 2020;22(10):e23173.","journal-title":"J Med Internet Res"},{"key":"28108_CR30","unstructured":"Centers for Medicare & Medicaid Services. National Plan and Provider Enumeration System (NPPES) national provider identifier (NPI) downloadable file. In: Services CfMM, editor. Baltimore, MD, 2023. https:\/\/download.cms.gov\/nppes\/NPI_Files.html."},{"key":"28108_CR31","volume-title":"Medi-Cal Managed Care Provider Listing Sacramento","author":"California Department of Health Care Services","year":"2023","unstructured":"California Department of Health Care Services. Medi-Cal Managed Care Provider Listing Sacramento. CA: California Department of Health Care Services; 2023."},{"issue":"2","key":"28108_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Stat Soc Ser B: Stat Methodol. 2005;67(2):301\u201320.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol"},{"key":"28108_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"issue":"3","key":"28108_CR34","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M. Classification and regression by randomForest. R news. 2002;2(3):18\u201322.","journal-title":"R news"},{"issue":"2","key":"28108_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/insr.12400","volume":"88","author":"J Wakefield","year":"2020","unstructured":"Wakefield J, Okonek T, Pedersen J. Small area estimation for disease prevalence mapping. Int Stat Rev. 2020;88(2):398\u2013418.","journal-title":"Int Stat Rev"},{"issue":"1","key":"28108_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12913-017-2137-z","volume":"17","author":"OV Mabikwa","year":"2017","unstructured":"Mabikwa OV, Greenwood DC, Baxter PD, Fleming SJ. Assessing the reporting of categorised quantitative variables in observational epidemiological studies. BMC Health Serv Res. 2017;17(1):201.","journal-title":"BMC Health Serv Res"},{"key":"28108_CR37","doi-asserted-by":"publisher","first-page":"103930","DOI":"10.1016\/j.drugpo.2022.103930","volume":"112","author":"SM Walters","year":"2023","unstructured":"Walters SM, Frank D, Felsher M, Jaiswal J, Fletcher S, Bennett AS, et al. How the rural risk environment underpins hepatitis C risk: qualitative findings from rural southern Illinois, United States. Int J Drug Policy. 2023;112:103930.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"28108_CR38","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.4254\/wjh.v16.i8.1091","volume":"16","author":"M Alenzi","year":"2024","unstructured":"Alenzi M, Almeqdadi M. Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes. World J Hepatol. 2024;16(8):1091.","journal-title":"World J Hepatol"},{"issue":"1","key":"28108_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/03091325211052040","volume":"46","author":"B King","year":"2022","unstructured":"King B, Rishworth A. Infectious addictions: Geographies of colliding epidemics. Prog Hum Geogr. 2022;46(1):139\u201355.","journal-title":"Prog Hum Geogr"},{"key":"28108_CR40","doi-asserted-by":"crossref","unstructured":"Di Ciaccio M, Villes V, Perfect C, El Kaim J, Donatelli M, James C, et al. Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey. Harm Reduct J. 2023;20(1):15.","DOI":"10.1186\/s12954-023-00743-8"},{"key":"28108_CR41","doi-asserted-by":"crossref","unstructured":"Solomon SS, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, et al. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: a cluster-randomized trial. J Hepatol. 2020;72(1):67\u201374.","DOI":"10.1016\/j.jhep.2019.09.022"},{"issue":"1","key":"28108_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2288-12-21","volume":"12","author":"C Bennette","year":"2012","unstructured":"Bennette C, Vickers A. Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents. BMC Med Res Methodol. 2012;12(1):21.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"28108_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11524-017-0185-7","volume":"95","author":"B Boodram","year":"2018","unstructured":"Boodram B, Hotton AL, Shekhtman L, Gutfraind A, Dahari H. High-risk geographic mobility patterns among young urban and suburban persons who inject drugs and their injection network members. Urban Health. 2018;95(1):71\u201382.","journal-title":"Urban Health"},{"key":"28108_CR44","doi-asserted-by":"publisher","first-page":"115943","DOI":"10.1016\/j.socscimed.2023.115943","volume":"326","author":"LG Goetschius","year":"2023","unstructured":"Goetschius LG, Henderson M, Han F, Mahmoudi D, Perman C, Haft H, et al. Assessing performance of ZCTA-level and Census Tract-level social and environmental risk factors in a model predicting hospital events. Soc Sci Med. 2023;326:115943.","journal-title":"Soc Sci Med"},{"issue":"5","key":"28108_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/aje\/kwf068","volume":"156","author":"N Krieger","year":"2002","unstructured":"Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian S, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471\u201382.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28108-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28108-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28108-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:14:02Z","timestamp":1786007642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28108-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28108"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28108-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Los Angeles County Department of Public Health Institutional Review Board (IRB Project No. 2024-07-002) and the University of Southern California Institutional Review Board (Study ID: UP-24-01157). The requirement for informed consent was waived by both Institutional Review Boards because the study used secondary, de-identified surveillance and area-level data. All procedures were conducted in accordance with relevant institutional guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2297"}}